Wagstaff J - Search Results

1

Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.

Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Bouma-ter Steege JC, Wagstaff J, Griffioen AW. Dirkx AE, et al. Among authors: wagstaff j. Cancer Res. 2003 May 1;63(9):2322-9. Cancer Res. 2003. PMID: 12727857

2

Angiogenic profile of breast carcinoma determines leukocyte infiltration.

Bouma-ter Steege JC, Baeten CI, Thijssen VL, Satijn SA, Verhoeven IC, Hillen HF, Wagstaff J, Griffioen AW. Bouma-ter Steege JC, et al. Among authors: wagstaff j. Clin Cancer Res. 2004 Nov 1;10(21):7171-8. doi: 10.1158/1078-0432.CCR-04-0742. Clin Cancer Res. 2004. PMID: 15534089

3

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

Dirkx AE, oude Egbrink MG, Castermans K, van der Schaft DW, Thijssen VL, Dings RP, Kwee L, Mayo KH, Wagstaff J, Bouma-ter Steege JC, Griffioen AW. Dirkx AE, et al. Among authors: wagstaff j. FASEB J. 2006 Apr;20(6):621-30. doi: 10.1096/fj.05-4493com. FASEB J. 2006. PMID: 16581970

4

Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment.

Baeten CI, Wagstaff J, Verhoeven IC, Hillen HF, Griffioen AW. Baeten CI, et al. Among authors: wagstaff j. Br J Cancer. 2002 Jul 29;87(3):344-7. doi: 10.1038/sj.bjc.6600457. Br J Cancer. 2002. PMID: 12177806 Free PMC article.

5

The antiangiogenic properties of bactericidal/permeability-increasing protein (BPI).

van der Schaft DW, Wagstaff J, Mayo KH, Griffioen AW. van der Schaft DW, et al. Among authors: wagstaff j. Ann Med. 2002;34(1):19-27. doi: 10.1080/078538902317338607. Ann Med. 2002. PMID: 12014429 Free article. Review.

6

The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.

van der Schaft DW, Dings RP, de Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, Bouma-Ter Steege JC, Wagstaff J, Mayo KH, Griffioen AW. van der Schaft DW, et al. Among authors: wagstaff j. FASEB J. 2002 Dec;16(14):1991-3. doi: 10.1096/fj.02-0509fje. Epub 2002 Oct 18. FASEB J. 2002. PMID: 12397082

7

Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.

Dirkx AE, Oude Egbrink MG, Wagstaff J, Griffioen AW. Dirkx AE, et al. Among authors: wagstaff j. J Leukoc Biol. 2006 Dec;80(6):1183-96. doi: 10.1189/jlb.0905495. Epub 2006 Sep 22. J Leukoc Biol. 2006. PMID: 16997855 Review.

8

[Angiogenesis and the regulation of antitumor defense].

Pappas NP, Hillen HF, Wagstaff J, Griffioen AW. Pappas NP, et al. Among authors: wagstaff j. Ned Tijdschr Geneeskd. 1999 Jul 24;143(30):1555-9. Ned Tijdschr Geneeskd. 1999. PMID: 10443280 Review. Dutch.

9

Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.

Mulder WM, Stern PL, Stukart MJ, de Windt E, Butzelaar RM, Meijer S, Adér HJ, Claessen AM, Vermorken JB, Meijer CJ, Wagstaff J, Scheper RJ, Bloemena E. Mulder WM, et al. Among authors: wagstaff j. Clin Cancer Res. 1997 Nov;3(11):1923-30. Clin Cancer Res. 1997. PMID: 9815581

10

A systematic review of the relation between interleukin-2 schedule and outcome in patients with metastatic renal cell cancer.

Baaten G, Voogd AC, Wagstaff J. Baaten G, et al. Among authors: wagstaff j. Eur J Cancer. 2004 May;40(8):1127-44. doi: 10.1016/j.ejca.2004.02.010. Eur J Cancer. 2004. PMID: 15110876 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters